While it was initially developed for type 2 diabetes management, liraglutide is also FDA-approved under the brand name Saxenda for chronic weight management in adults with obesity or overweight who have weight-related health conditions
Aronne LJ, Sattar N, Horn DB, Bays HE, Wharton S, Lin WY, Ahmad NN, Zhang S, Liao R, Bunck MC, Jouravskaya I, Murphy MA, SURMOUNT-4 Investigators (2024) Continued treatment with tirzepatide for maintenance of weight reduction in adults with obesity: the SURMOUNT-4 randomized clinical trial
Glutathione peroxidase 1 (Gpx1) is first identified as a selenium-dependent enzyme in 1973 and has a role as antioxidant enzyme
Women of childbearing potential must use effective contraception throughout treatment